Serina Therapeutics, Inc. Warrant, Exercise Price, Decrease
Serina Therapeutics, Inc. (SER) reported Warrant, Exercise Price, Decrease of $0.70 per share for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2021-11-12
- 2021-09-30: Warrant, Exercise Price, Decrease 9 month $0.70.
| Period end | Warrant, Exercise Price, Decrease 9 month |
|---|---|
| 2021-09-30 | $0.70 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |